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Breast cancer is the most common cancer in women in most low- 
and middle-income countries (LMICs), including South Africa (SA), 
where it is the most common cancer histologically diagnosed in 
women, with a lifetime risk of 1 in 26[1] and causing at least 0.9% of all 
deaths in 2015.[2] Although breast cancer has a good overall prognosis 
in comparison with many other cancers, with an 84 - 89% survival 
rate at 5 years reported in high-income countries, in LMICs these 
rates are substantially lower and the majority of women diagnosed 
with breast cancer will succumb to the disease. Mortality rates at 
5 years of 47% in SA and 86.4% in Mali have been reported.[3] This 
high diagnosis-to-mortality ratio could be attributable to late stage 
at presentation, as reported in most literature from LMICs, which 
would affect prognosis irrespective of the care available.
In SA, the National Department of Health recently launched a 
national Breast Cancer Prevention and Control Policy[4] outlining 
standards to which healthcare providers should adhere when 
providing care. Many of the standards and much of the publicity 
around the policy have focused on cancer care provision through 
better therapeutic modalities, such as access to chemotherapy and 
novel monoclonal antibody therapies.[5] However, in addition to 
provision of breast cancer care at tertiary services, ensuring access 
to early diagnosis and recognition of disease are of equal if not more 
importance. Where resources are limited, many expensive modalities 
of care may be avoided with prompt presentation and early diagnosis.
While small studies from various parts of the world suggest that 
patient-related delay to care is common,[6-10] the characteristics of 
delay and its relationship to stage of breast cancer presentation are 
still poorly documented, especially in southern Africa. Older studies 
have cited fear of mastectomy and adherence to traditional healing as 
causes of delay,[7,11,12] but more recent studies and systematic reviews 
show extremes of age (the youngest and oldest patients being most 
affected), marital status, education and income as being of most 
importance.[13]
Objectives
SA is a middle-income country where open-access tertiary hospitals 
can provide care, but deep-rooted inequities may prevent access to it by 
all the population. This study was designed to define the relationship 
between socioeconomic characteristics of patients seeking care at a 
tertiary specialist clinic and to describe where patient-related delays 
occur and how these relate to stage at presentation, which ultimately 
affects treatment requirements and survival. 
Methods
This study was conducted in one of the few specialist breast-care 
clinics in SA where an open-access system allows all patients to attend 
without previous appointment or referral for breast examination and 
investigation. The format of this clinic and the spectrum of disease 
have been described previously,[14] and the clinic currently diagnoses 
and manages >300 new diagnoses of breast cancer per year.
Over a 14-month period from January 2016 to February 2017, all 
patients who received a new breast cancer diagnosis were approached 
by a clinician during their post-result counselling and asked if they 
would participate in the study. After written consent had been 
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obtained, they were asked questions from, or completed themselves, 
a previously piloted questionnaire regarding their demographics, 
socioeconomic situation, education and self-described ability to 
access care.[15] Participants were asked to quantify how long it took 
them to acknowledge or disclose a breast symptom once noticed, 
from that point how long before they visited any health facility, 
and from that point how long before they attended the open-access 
breast-care clinic for diagnosis. The language of the questionnaire 
was English, although each of two research assistants involved in 
participant recruitment were fluent in at least two languages, and 
assistance was sought from other staff members to allow participants 
to complete the questionnaire in a language most comfortable for 
them, through immediate verbal translation. The results of the 
questionnaire were linked via a study number to the patient’s clinical 
stage at presentation, as documented by the diagnosing breast 
specialist surgeon. Ethical approval was received from the Human 
Research Ethics Committee of the University of the Witwatersrand, 
Johannesburg (ref. no. M111121).
The data were collected using REDCap (hosted by the University 
of the Witwatersrand) to enter and manage the data,[16] and all 
statistical analyses were done in Stata version 13.1 (StataCorp, 
USA). Patient characteristics were described using frequencies and 
proportions, and age was categorised as <45 years or ≥45 years. 
Marital status was categorised as either married or unmarried, 
the latter including participants who were single, divorced or 
widowed. Education was categorised according to the highest level of 
formal schooling obtained: completed primary schooling, completed 
secondary schooling, or matriculation from school with or without 
qualifications above that.
Participants who indicated that they had at least some difficulty 
with transportation or taking time off from work were compared 
with those who did not. Fear regarding missing an appointment or 
required attendance at the hospital due to work, money or transport 
problems was indicated on a four-category summative scale (from 
strongly agree to strongly disagree) and those who expressed some 
fear (agree or strongly agree) were compared with those who did 
not express any fear. Time to presentation comprised time taken 
to acknowledge symptom(s), time to seek healthcare services, and 
time taken to attend a breast-care clinic. To facilitate responses, 
participants were offered categories of <1 week, 1 week - 1 month, 
1 - 6 months, 6 - 12 months, or >1 year. To facilitate summation and 
analysis of the total delay numerically, these were then converted into 
total days of delay, which were created by taking the minimum time 
for each response, e.g. <1 week = 1 day, 1 week – 1 month = 8 days, 
1 month - 6 months = 31 days, 6 months - 1 year = 182 days and 
>1 year = 366 days.
Clinical stage at presentation was described using the TNM 
classification (8th edition),[17] and stage was determined. Stage was 
then categorised into early (stage 1 - stage 2a) and locally advanced 
(stage 2b - stage 3c). For determination of delay by stage, patients 
with stage 0 were excluded because of the relationship with screening 
rather than clinically detected disease in this group. Stage 4 was 
also excluded because these patients commonly follow a route to 
medical oncological care that may bypass a surgical clinic. Two-sided 
differences of proportions were compared using Pearson’s χ2 test. 
Categorised delay was compared using ordinal logit. A p-value ≤0.05 
was considered statistically significant.
Results
Over 14 months from January 2016 to February 2017, 352 patients 
received a new diagnosis of breast cancer. A total of 252 patients 
with newly diagnosed stage 1 - 3 breast cancer completed the 
questionnaire, giving a response rate of 71.6%. Their median age was 
55 years (interquartile range (IQR) 44 - 65), with 59 (26.5%) aged 
<45 years. Stage was recorded for 232 patients (92.1%), with stage at 
presentation stage 1 in 36 (15.5%), stage 2 in 66 (28.5%) and stage 3 in 
130 (56.0%). Nearly one-third of all patients presented with T4 cancer 
(either T4d inflammatory (6.1%) or involving skin above or muscle 
below (24.3%)). When stage was categorised, it was found that only 
32.3% of patients presented with early-stage breast cancer.
Key demographics, presented according to early or advanced stage 
at diagnosis, are set out in Table 1. There were very few relationships 
between any patient-reported fears or socioeconomic characteristics 
and stage of disease, but self-reported transport difficulties (p=0.011) 
and having a cell phone (mobile phone) contract (p=0.035) were 
significantly associated with locally advanced disease at presentation. 
Total delay in presenting at the breast clinic was statistically associated 
with locally advanced stage at presentation (p=0.021).
Self-reported median delay to presentation at a breast unit was 
2 months (IQR 1 - 7) after noticing a symptom. Total delay differed 
according to whether patients were diagnosed with early-stage 
disease (1.5 months, IQR <1 - 6) or disease at a locally advanced stage 
(2.5 months, IQR 1 - 7). When the data on this delay were separated 
out and analysed, most of the delay occurred during the period 
between a woman acknowledging a problem and attending a health 
service. This delay was a median of 1 week (IQR 1 day - 1 month) 
in early-stage and 1 month (IQR 1 day - 3 months) in locally 
advanced breast cancer. The least delay was between attending a 
health service and presenting at the specialist breast-care clinic, with 
a median of 1 week (IQR 1 day - 1 month) in early-stage v. 1 month 
(IQR 1 week - 1 month) in locally advanced disease, and 75.0% of all 
study participants attended within 1 month (early stage 79.7%, locally 
advanced 72.1%).
The relationship of each part of the delay to stage of disease is 
indicated in Fig. 1, with total delay for comparison. It is evident 
that, while there is a person-by-person variation in timeline to care, 
patients with early stage-disease tended to attend each part of their 
pathway more timeously. The most notable difference between 
patients with early and locally advanced disease was in time to 
acknowledging a symptom, whereas time to healthcare services and 
time to specialist care were similar (Fig. 1, A, B and C, respectively).
Similar to the analysis by stage, there were few patient characteristics 
associated with increased total delay; only travel time to hospital 
was found to be statistically significant (p<0.001). When delay was 
separated into its three constituents, lack of internet access was 
associated with delay in acknowledging breast symptoms (p=0.051). 
Having someone in the family with breast cancer was also associated 
with a delay of >6 months in acknowledging breast symptoms 
(p=0.028). Fear of missing work due to appointments was associated 
with delay in accessing any healthcare services (p=0.04). This delay 
in accessing healthcare services was also significantly more likely in 
patients with a low education (up to Grade 7) (p=0.008).
Discussion
This study was designed to evaluate the pre-diagnostic timeline of 
patients newly diagnosed with breast cancer in an urban specialist 
breast clinic. We aimed to determine the relationship between delay 
to definitive breast cancer diagnosis, stage of disease at presentation 
and the socioeconomic characteristics that have previously been 
described as risk factors for delay to care in other resource-limited 
settings. We expected to reproduce the findings that delay was related 
to stage, and that both delay and stage would be related to some of the 
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Table 1. Patient characteristics by stage of disease
Description
Stage at presentation, n (%)
p-value†
Early 
(1 - 2a)
Locally advanced 
(2b - 3c)
All participants 75 (32.3) 157 (67.7)
Age (years) (N=223) 0.072
<45 14 (23.7) 45 (76.3)
≥45 60 (36.6) 104 (63.4)
Marital status (N=222) 0.601
Married or in relationship 38 (34.6) 72 (65.5)
Not in relationship 35 (31.3) 77 (68.8)
Education (N=218) 0.516
Only primary school 21 (30.4) 48 (69.6)
Secondary school or above 52 (34.9) 97 (65.1)
Family history 0.733
Breast cancer in close family 6 (28.6) 15 (71.4)
No breast cancer in family 67 (32.2) 141 (67.8)
Dependants (N=199) 0.936
None 17 (32.7) 35 (67.3)
1 - 3 22 (34.9) 41 (65.1)
>3 27 (32.1) 57 (67.9)
Cell phone (mobile phone) (N=205) 0.035*
Contract (billed) 6 (17.7) 28 (82.4)
Airtime top-up 62 (36.3) 109 (63.7)
Internet use (N=219) 0.133
None 51 (35.9) 91 (64.1)
Occasionally or daily 20 (26.0) 57 (74.0)
Employment status (N=221) 0.262
Unemployed, piece work, student or retired 55 (34.8) 103 (65.2)
Employed, job 17 (27.0) 46 (73.0)
Transport to breast clinic (N=219) 0.011*
Not difficult 63 (37.3) 106 (62.7)
Burdensome 9 (18.0) 41 (82.0)
Travel to breast clinic (N=218) 0.790
<30 minutes 12 (30.8) 27 (69.2)
30 minutes - 1 hour 26 (35.1) 73 (69.5)
1 - 4 hours 26 (35.1) 48 (64.9)
Fears about missing appointments
Due to work (N=143) 10 (33.3) 20 (66.7) 0.732
Due to transport (N=213) 16 (25.4) 47 (74.6) 0.133
Due to money (N=213) 25 (27.5) 66 (72.5) 0.185
Due to family obligations (N=207) 19 (40.4) 28 (59.6) 0.179
Total delay to presentation at breast clinic (N=206) 0.021*
<1 month 16 (43.2) 21 (56.8)
1 - 6 months 23 (30.3) 53 (69.7)
6 - 12 months 18 (42.9) 24 (57.1)
>1 year 3 (11.1) 24 (88.9)
Delay to acknowledgement (N=206) 0.296
<1 week 23 (34.3) 44 (65.7)
<1 month 17 (40.5) 25 (59.5)
1 - 6 months 15 (29.4) 36 (70,6)
>6 months 10 (22.2) 35 (77.8)
Delay to any health facility (N=206) 0.361
<1 week 19 (35.9) 34 (64.2)
<1 month 29 (36.4) 53 (64.6)
1 - 6 months 11 (22.0) 39 (78.0)
>6 months 6 (28.6) 15 (71.4)
Continued ...
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common risk factors for inequitable access 
to care seen in our environment, namely 
low income, low education, insecure job 
circumstances and poor access to transport 
and money. The significant relationship of 
a cell phone contract (as opposed to top-
up, indicating a more financially secure 
population) with locally advanced disease 
was an unexpected finding that requires 
more investigation.
In this study, a heterogeneous group of 
newly diagnosed participants was identified 
with few characteristics that defined them as 
at risk of presenting with locally advanced 
disease. However, it is worth pointing 
out some of the characteristics that make 
breast cancer a particular problem in 
our environment. More than a quarter of 
the newly diagnosed patients were aged 
<45 years. This has been a consistent find-
ing in breast cancer studies in SA[2,18] and may 
be a result of bias due to a younger overall 
population in SA, a younger population in 
this urban sample, or absence in this SA 
sample of the more biologically indolent 
cancers detected by screening older women 
in high-income settings. This is a younger 
cohort of women at risk of the disease than 
may be expected by healthcare practitioners, 
who therefore might not consider a breast 
cancer diagnosis possible or likely. Studies 
of provider-associated delays cite a lack 
of knowledge of breast cancer symptoms 
among providers, with inappropriate 
reassurance[10,19,20] that could delay onward 
referral, specifically in younger patients.
Two-thirds of our patients presented with 
a locally advanced breast cancer (stage 2a - 
3c) with disease in both the breast and axilla, 
with a high risk of systemic micrometastatic 
disease. Almost all these patients require 
multimodality therapy, with chemotherapy, 
surgery and radiation all indicated.[21] 
This requirement for additional therapies 
highlights the fact that late presentation 
in breast cancer is a crisis not only for the 
patient but also for the healthcare system. 
The earlier the cancer is diagnosed, the less 
likely it is that expensive and heavily under-
resourced therapies such as radiation will 
be required. One-quarter of all our patients 
presented with a tumour that was ulcerating 
or fixed to the skin and surrounding tissues, 
but there was no relationship between this 
finding and any self-reported delay.
Many studies in sub-Saharan Africa have 
described significant delays to presenta-
tion. [6,10,13,19,22-25] In the present study, the 
average time to presentation at the breast 
clinic was 2 months from the time of noticing 
any symptoms, which is shorter than in many 
other African studies, where delay can be 
measured in years, but comparable to study 
groups from urban populations in other 
upper-middle-income countries worldwide. 
In Malaysia, 56% of patients presented 
over 3 months from the time of noticing 
symptoms;[26] in Brazil this figure was 70%[27] 
and in Mexico it was 73.7%.[28] The only 
outlier in this group was in Thailand,[29] 
where only 17% of patients presented after 
3 months. However, this study of tertiary 
facilities in northern Thailand showed that 
88% of all patients had a first consultation 
with a doctor, and for 89% of all patients 
this was in a hospital, thereby lessening 
the patient-related access issues of multiple 
visits, which can slow the progress of a 
patient through many tiers of the healthcare 
service towards tertiary or definitive care.[14] 
In our study, the least delay in both early and 
locally advanced patients was seen between 
attending any healthcare services and 
attending the specialist clinic, with >75.0% 
seen within 1 month, which confirms 
the improved accessibility for patients of 
open-access care and its contribution in 
Table 1. (continued) Patient characteristics by stage of disease
Description
Stage at presentation, n (%)
p-value†
Early 
(1 - 2a)
Locally advanced 
(2b - 3c)
Delay to specialist breast clinic (N=206) 0.257
<1 week 34 (34.0) 66 (66.0)
<1 month 21 (35.0) 39 (65.0)
1 - 6 months 12 (32.4) 25 (67.6)
>6 months 2 (11.1) 16 (88.9)
*Statistically significant values (p<0.05).
†p-values calculated using Pearson χ2 difference of proportions. 
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Fig. 1. Delay to presentation in patients with early and locally advanced disease: A = time to 
acknowledging a symptom; B = time from acknowledgement to any heath facility; C = time from any 
health facility to specialist care; D = total time from symptom to specialist care.
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preventing delay. However, this improved access is dependent on 
community knowledge of the facility and highlights the importance 
of community education and awareness, not just of breast symptoms 
but of the local facilities equipped to manage them.
Whether our results from an urban tertiary centre are generalisable 
more widely in SA, particularly in more rural areas, is uncertain. SA 
is becoming increasingly urbanised, and the populations in urban 
centres are growing. These populations tend to be young and may 
share many of the characteristics of our study population. There is 
access to tertiary breast cancer services in most of the main cities in 
SA, and our findings can therefore inform other clinicians regarding 
the characteristics of their patients, and directions for future research 
around access to breast cancer care. They can also highlight to 
government the importance of a multimodal method of improving 
cancer care – addressing education and awareness, but also opening 
up access to care to facilitate early diagnosis.
Study limitations
The limitations of this study should be acknowledged. Many patients 
with breast cancer may not present until the very latest stages, where 
palliation is appropriate and up-referral for interventional therapy 
is decided against. Lack of a comprehensive screening programme 
also means that most breast cancer is detected after a clinical 
symptom, which will predispose toward a later stage. There may be 
women, even in urban environs, who never reach the specialist clinic 
despite open-access facilities. It is notoriously hard to characterise 
these women, but it can only be assumed that they are more likely 
to have late-stage disease (indeed end-stage disease) and have the 
longest time to presentation. This is an important source of selection 
bias in this current study, but one that is difficult to overcome. 
Additionally, some women may not accurately remember when 
they first acknowledged symptoms, or the time taken to attend for 
care. This would be likely to affect all women equally, however, and 
therefore not attract bias on the comparison of stage and time to 
presentation.
Conclusions
Despite an increase in breast cancer awareness in SA and the recent 
national Breast Cancer Prevention and Control Policy, two-thirds of 
our patients presented with locally advanced breast cancer. While 
women with transport problems and work fears were more likely to 
present with locally advanced disease, there were few socioeconomic 
characteristics that could identify those at risk of delay to presentation. 
Most women delayed longer than recommended in both seeking 
any care and attending specialist breast care. Although time to 
acknowledge a symptom was associated with the most delay, the 
reduction in time to specialist care in these circumstances supports 
the availability of open-access care to facilitate access to care once 
symptoms are recognised.
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